Michel Ibrahim1, Garly Rushler Saint Croix2, Spencer Lacy3, Sandra Chaparro4. 1. Division of Cardiovascular Medicine, Department of Medicine, Boston University Medical Center, Boston University School of Medicine, Boston, MA, USA. 2. Division of Cardiology at Mount Sinai Medical Center, Columbia University, Miami Beach, FL, USA. 3. Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. 4. Department of Medicine, Baptist Health South F1orida, Miami, FL, USA.
Abstract
Background and Objectives: Renal dysfunction is a common comorbidity in patients with advanced heart failure who may benefit from left ventricular assist device (LVAD) therapy. The effect of preoperative renal dysfunction on clinical outcomes after LVAD implantation remains uncertain. We conducted a systematic review and meta-analysis to compare outcomes post-LVAD in patients with and without renal dysfunction. Methods: PubMed, MEDLINE, and Embase databases were searched for studies comparing outcomes in patients with and without renal dysfunction who underwent LVAD implantation for advanced heart failure. The primary outcome of all-cause mortality was reported as random effects risk ratio (RR) with 95% confidence interval (CI). Results: Our search yielded 5,229 potentially eligible studies. We included 7 studies reporting on 26,652 patients. Patients with renal dysfunction (glomerular filtration rate [GFR] <60 mL/min/1.73 m2) (n=4,630) had increased risk of all-cause mortality (RR, 2.21; 95% CI, 1.39-3.51; p<0.01) compared to patients with normal renal function (GFR >60 mL/min/1.73 m2) (n=22,019). Conclusions: Patients with renal dysfunction have increased mortality after LVAD implantation when compared to patients with normal renal function. GFR can be used to risk stratify patients and guide decision making prior to LVAD therapy.
Background and Objectives: Renal dysfunction is a common comorbidity in patients with advanced heart failure who may benefit from left ventricular assist device (LVAD) therapy. The effect of preoperative renal dysfunction on clinical outcomes after LVAD implantation remains uncertain. We conducted a systematic review and meta-analysis to compare outcomes post-LVAD in patients with and without renal dysfunction. Methods: PubMed, MEDLINE, and Embase databases were searched for studies comparing outcomes in patients with and without renal dysfunction who underwent LVAD implantation for advanced heart failure. The primary outcome of all-cause mortality was reported as random effects risk ratio (RR) with 95% confidence interval (CI). Results: Our search yielded 5,229 potentially eligible studies. We included 7 studies reporting on 26,652 patients. Patients with renal dysfunction (glomerular filtration rate [GFR] <60 mL/min/1.73 m2) (n=4,630) had increased risk of all-cause mortality (RR, 2.21; 95% CI, 1.39-3.51; p<0.01) compared to patients with normal renal function (GFR >60 mL/min/1.73 m2) (n=22,019). Conclusions: Patients with renal dysfunction have increased mortality after LVAD implantation when compared to patients with normal renal function. GFR can be used to risk stratify patients and guide decision making prior to LVAD therapy.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Javed Butler; Carrie Geisberg; Renee Howser; Peer M Portner; Joseph G Rogers; Mario C Deng; Richard N Pierson Journal: Ann Thorac Surg Date: 2006-05 Impact factor: 4.330
Authors: Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz Journal: J Am Coll Cardiol Date: 2004-01-07 Impact factor: 24.094
Authors: Nicholas C Dang; Veli K Topkara; Michelle Mercando; Joy Kay; Kurt H Kruger; Michael S Aboodi; Mehmet C Oz; Yoshifumi Naka Journal: J Heart Lung Transplant Date: 2005-12-09 Impact factor: 10.247
Authors: J Thomas Heywood; Gregg C Fonarow; Maria Rosa Costanzo; Vandana S Mathur; John R Wigneswaran; Janet Wynne Journal: J Card Fail Date: 2007-08 Impact factor: 5.712
Authors: Christopher M O'Connor; Robert J Mentz; Gad Cotter; Marco Metra; John G Cleland; Beth A Davison; Michael M Givertz; George A Mansoor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Mona Fiuzat; Daniel Wojdyla; Karen Chiswell; Barry M Massie Journal: Eur J Heart Fail Date: 2012-04-25 Impact factor: 15.534
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Francis D Pagani; Susan L Myers; Lynne W Stevenson; Michael M Givertz; James B Young Journal: J Heart Lung Transplant Date: 2013-10-08 Impact factor: 10.247
Authors: Robert L Kormos; Jeffrey J Teuteberg; Francis D Pagani; Stuart D Russell; Ranjit John; Leslie W Miller; Todd Massey; Carmelo A Milano; Nader Moazami; Kartik S Sundareswaran; David J Farrar Journal: J Thorac Cardiovasc Surg Date: 2010-02-04 Impact factor: 5.209